Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Poststress Block of Kappa Opioid Receptors Rescues Long-Term Potentiation of Inhibitory Synapses and Prevents Reinstatement of C
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Antagonists of the kappa opioid receptor - ScienceDirect
The Kappa Opioid Receptor: From Addiction to Depression, and Back | Semantic Scholar
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology
κ-opioid receptor - Wikipedia
Focusing on the Opioid System for Addiction Biomarker Discovery: Trends in Molecular Medicine
Drug Addiction Pipeline Drugs Market by Stages, Target & Key Players, 2022 Update
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Kappa-opioid receptor-selective antagonism by zyklophin.... | Download Scientific Diagram
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat | Request PDF
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
